Dayvigo (Lemborexant)

Dayvigo (lemborexant) is a prescription medicine for adults with insomnia who have difficulty falling asleep and/or staying asleep. The recommended dose is 5 mg taken once per night immediately before going to bed, with at least 7 hours remaining before planned waking; it may be increased to 10 mg.

Lemborexant blocks orexin receptors (OX1R and OX2R) in the brain. Orexin is a neuropeptide that promotes wakefulness, so blocking it helps the brain move into and stay in sleep.

• It can cause next-morning drowsiness and impaired driving ability, especially at 10 mg; patients should be cautious the next day.
• Contraindicated in narcolepsy. Sleep paralysis, hallucinations and cataplexy-like symptoms can occur.
• Complex sleep behaviours, worsening depression or suicidal thinking should be reported promptly.
• Avoid alcohol and strong CYP3A inhibitors or inducers. Lemborexant is a Schedule IV controlled substance in the US.

How can a patient in India get Dayvigo?

Dayvigo is an imported medicine and is not readily available through regular pharmacies in India. It can still be accessed legally on a named-patient basis, subject to Indian import regulations.

What do I need to provide?

• A valid prescription from a registered psychiatrist, neurologist or sleep specialist
• Clinical assessment confirming insomnia
• Patient ID proof issued by the Government of India

Is the order confirmed straight away?

No. We confirm it only once a valid prescription has been received and verified.

Indian Pharma Network (IPN) sources Dayvigo through its authorised distribution network and arranges supply to patients, doctors and hospitals within the applicable legal framework.

For the current price of Dayvigo in India and expected delivery time, call +91-9310090915 or email info@indianpharmanetwork.in.

Global Approval Status:

• United States: FDA-approved in December 2019.
• Japan: Approved in 2020.

What does Dayvigo treat?

It is a dual orexin receptor antagonist, prescribed for insomnia in adults.

Which company makes Dayvigo?

Eisai.

How is Dayvigo different from Belsomra?

Both are orexin receptor antagonists for insomnia; they are different molecules (lemborexant vs suvorexant) with different doses and dosing details.

What is the mechanism of Dayvigo?

Lemborexant blocks orexin receptors (OX1R and OX2R) in the brain.

Does Dayvigo have FDA approval?

Yes. Dayvigo is FDA-approved for adults with insomnia characterised by difficulty with sleep onset and/or sleep maintenance.